135 related articles for article (PubMed ID: 154330)
1. Differential sensitivity of functional subsets of T cells to the cytotoxicity of natural T-lymphocytotoxic autoantibody of systemic lupus erythematosus.
Koike T; Kobayashi S; Yoshiki T; Itoh T; Shirai T
Arthritis Rheum; 1979 Feb; 22(2):123-9. PubMed ID: 154330
[TBL] [Abstract][Full Text] [Related]
2. Subpopulation of T cells sensitive to natural thymocytotoxic autoantibody (NTA) of New Zealand mice. I. Distinct cytotoxic sensitivity of functional T cell subsets to NTA and anti-thy-1 antibodies.
Nagata N; Suda K; Maruyama N; Koike T; Shirai T
Microbiol Immunol; 1982; 26(5):411-22. PubMed ID: 6981749
[TBL] [Abstract][Full Text] [Related]
3. Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells.
Sakane T; Steinberg AD; Green I
Arthritis Rheum; 1978; 21(6):657-64. PubMed ID: 153749
[TBL] [Abstract][Full Text] [Related]
4. Studies of anti-lymphocyte antibody of patients with active SLE. I. Cause of loss of suppressor T-lymphocyte function.
Morimoto C; Abe T; Toguchi T; Kiyotaki M; Homma M
Scand J Immunol; 1979; 10(3):213-21. PubMed ID: 160612
[TBL] [Abstract][Full Text] [Related]
5. In vitro functional characterization of SAG-3--a naturally occurring monoclonal antibody in NZB mice: specificity toward functional T cell subsets.
Surh CD; Ansari A; Gershwin ME
Hybridoma; 1988 Dec; 7(6):609-25. PubMed ID: 2976731
[TBL] [Abstract][Full Text] [Related]
6. Induction of autoimmune phenomena in normal mice treated with natural thymocytotoxic autoantibody.
Nakanishi A; Imai Y; Nakano T; Osawa T
J Immunol; 1982 May; 128(5):2137-41. PubMed ID: 6460818
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte rosette inhibition as an assay for naturally occurring T lymphocytotoxic antibody in systemic lupus erythematosus.
Koike T; Kobayashi S; Yoshiki T; Itoh T; Shirai T
Arthritis Rheum; 1979 Oct; 22(10):1064-73. PubMed ID: 314803
[TBL] [Abstract][Full Text] [Related]
8. Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML.
Huber C; Pfister R; Stingl G
Clin Exp Immunol; 1982 Dec; 50(3):525-33. PubMed ID: 6219834
[TBL] [Abstract][Full Text] [Related]
9. Studies of autologous mixed lymphocyte reactions in patients with systemic lupus erythematosus.
Russell PJ; Doolan TJ; Webb J; Carr GA
Pathology; 1983 Jan; 15(1):37-43. PubMed ID: 6134267
[TBL] [Abstract][Full Text] [Related]
10. Functional differences of anti-T-cell antibody in patients with systemic lupus erythematosus and ulcerative colitis.
Abe T; Morimoto C; Toguchi T; Kiyotaki M; Takeuchi T; Koide J; Asakura H; Tsuchiya M; Homma M
Scand J Immunol; 1983 Dec; 18(6):521-30. PubMed ID: 6229872
[TBL] [Abstract][Full Text] [Related]
11. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
[TBL] [Abstract][Full Text] [Related]
12. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
Sakane T; Steinberg AD; Reeves JP; Green I
J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
[TBL] [Abstract][Full Text] [Related]
13. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus.
Winfield JB; Shaw M; Minota S
J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614
[TBL] [Abstract][Full Text] [Related]
14. PHA-T cells in systemic lupus erythematosus and in rheumatoid arthritis: abnormalities in HLA class II antigen induction and in autologous mixed lymphocyte reactions.
Indiveri F; Scudeletti M; Pierri I; Traverso A; Cerri C; Ferrone S
Cell Immunol; 1986 Jan; 97(1):197-203. PubMed ID: 2943425
[TBL] [Abstract][Full Text] [Related]
15. A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.
Twomey JJ; Laughter AH; Steinberg AD
J Clin Invest; 1978 Sep; 62(3):713-5. PubMed ID: 308514
[TBL] [Abstract][Full Text] [Related]
16. Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus.
Sakane T; Steinberg AD; Green I
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3464-8. PubMed ID: 150602
[TBL] [Abstract][Full Text] [Related]
17. Phenotypes of T lymphocytes in systemic lupus erythematosus: decreased cytotoxic/suppressor subpopulation is associated with deficient allogeneic cytotoxic responses rather than with concanavalin A-induced suppressor cells.
Tsokos GC; Balow JE
Clin Immunol Immunopathol; 1983 Feb; 26(2):267-76. PubMed ID: 6223747
[TBL] [Abstract][Full Text] [Related]
18. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
19. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
Minota S; Winfield JB
J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to activated T cells and their soluble products in systemic lupus erythematosus.
Winfield JB; Cohen PL; Litvin DA
Arthritis Rheum; 1982 Jul; 25(7):814-9. PubMed ID: 7049185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
